Medipledge, a premium post-laser skincare brand, just launched in Australia

March 25, 2024 01:09 PM AEDT | By Cision

Google News:

Image source: Kalkine Media

Recent News

'Journey Through Time' is an enlightening exploration of RCIA by Laure...

“Life of Abuse to Success: A Child’s Story” is a poignant memoir of re...

CNH Expands Connectivity Solutions With SpaceX’s Starlink

Between Hunger and Hope: a Story of Humanity in the Heart of Gaza

SYDNEY, March 25, 2024 /PRNewswire/ -- On March 24th, 2024, Medipledge, a premium skincare brand developed by experts in beauty and dermatology, successfully launched in Australia.

The launch event, held in Australia, featured high-tech elements and included high-end aesthetic therapists, leading equipment suppliers, and influential local KOLs. Discussions centered on post-cosmetic treatment and the brand's unique product offerings.

Medipledge is committed to post-cosmetic treatment skin barrier restoration, based on principles of aesthetic dermatology and the theory of Skin Interactome. The brand's core philosophy focuses on catering to Asian skin, specializing in post-cosmetic treatment restoration, and earning the trust of dermatologists.

With advanced formulas inspired by the Skin Interactome theory, Medipledge offers a range of post-laser skin barrier restoration solutions, particularly for Asian type IV skin. The products, backed by extensive patent authorizations and cutting-edge technologies, undergo rigourous clinical testing to ensure safety and efficacy. Ingredients include PDRN (Salmon sperm protein extract), GP4G (Artemia extract), Centella asiatica extract, recombinant type III human collagen, and PhatNam nanoencapsulation penetration technology.

While the traditional concept of the skin barrier refers to the stratum corneum, Medipledge views the skin barrier as a multidimensional composition, encompassing the chemical barrier, microbiome barrier, physical barrier, light protection barrier, and immune barrier. Restoring the complete skin barrier after post-cosmetic treatment is essential. Both invasive and non-invasive cosmetic procedures can impact the skin barrier, and the components of the skin barrier interact with each other. Therefore, restoration should be done in stages, depending on the specific condition of the skin barrier.

Clinical trials for Medipledge products were conducted in hospital dermatology departments and cosmetic testing centres. A 6-8 month study involved 35 participants aged between 18 and 60, using a burst-mode fractional laser to assess the effects of the products on the skin. The rigour of these tests exceeds industry standards. After the launch, Medipledge products were utilized in the treatment of over 200 dermatological patients, producing noticeable results. This positions Medipledge uniquely in the skincare market, emphasizing its specialization in post-cosmetic treatment skin barrier restoration.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.